Cassaundra Acosta

Oct 21, 2024 | onlinelibrary.wiley.com | Robert Galamaga |Stephanie Johnston |Cassaundra Acosta

BACKGROUND Chemotherapy-induced thrombocytopenia (CIT) is a common complication of myelosuppressive chemotherapeutic regimens.1 Platelet counts (PC) <100 × 109/L increase the risk of bleeding and cancer complications, leading to poor overall survival.2 CIT management often involves chemotherapy treatment delays, dose reduction, and treatment interruption, reducing the relative dose intensity of treatment and leading to poor overall outcomes.2 CIT management aims to reduce bleeding risk and...